Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: NANOHMICS INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2025-08-01 to 2026-01-31
Current total value of award: $209573.26
Description: THIS SMALL BUSINESS INNOVATION RESEARCH PHASE I PROPOSAL WILL FOCUS ON DEVELOPING A DEOXYRIBONUCLEIC ACID BASED BINDER OF NEUROTOXINS THAT ALSO CATALYZES DEACTIVATION OF THE AGENT, RENDERING IT INEFFECTIVE AS A WARFARE WEAPON.